[1] |
Wang L, Cho KB, Li Y, et al. Long Noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer[J]. Int J Mol Sci, 2019, 20(22): 5758-5764. DOI: 10.3390/ijms20225758.
|
[2] |
Li X, Deng S, Pang X, et al. lncRNA NEAT1 silenced miR-133b promotes migration and invasion of breast cancer cells[J]. Int J Mol Sci, 2019, 20(15): 3616-3621. DOI: 10.3390/ijms20153616.
|
[3] |
庞其军, 赵颖, 郗艳国, 等. miR-134在人垂体腺瘤组织中的表达及其意义[J]. 现代生物医学进展, 2014, 14(17): 3328-3333. DOI: 10.13241/j.cnki.pmb.2014.17.034.
|
[4] |
马丽媛, 代从新. 抗血管内皮生长因子靶向治疗难治性垂体腺瘤和垂体腺癌研究进展[J]. 中国神经精神疾病杂志, 2020, 46(10): 625-628. DOI: 10.3969/j.issn.1002-0152.2020.10.011.
|
[5] |
Beylerli O, Khasanov D, Gareev I, et al. Differential non-coding RNAs expression profiles of invasive and non-invasive pituitary adenomas[J]. Noncoding RNA Res, 2021, 6(3): 115-122. DOI: 10.1016/j.ncrna.2021.06.004.
|
[6] |
Wang X, Li X, Wang Z. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes[J]. Oncol Rep,2021,45(4): 40-53.DOI: 10.3892/or.2021. 7991.
|
[7] |
倪文. lncRNA MIR4435-2HG靶向miR-1-3p调控信号通路PI3K/Akt对胰腺癌细胞增殖,侵袭和迁移的机制研究[J]. 安徽医药, 2021, 25(3): 467-473. DOI: 10.3969/j.issn.1009-6469.2021.03.009.
|
[8] |
Kou JT, Ma J, Zhu JQ, et al. lncRNA NEAT1 regulates proliferation, apoptosis and invasion of liver cancer[J]. Eur Rev Med Pharmacol Sci, 2020, 24(8): 4152-4160. DOI: 10.26355/eurrev_202004_20995.
|
[9] |
周建华, 胡涛, 陈宇, 等. lncRNA NEAT1在人脑胶质瘤的表达变化及其与病人预后的关系[J]. 中国临床神经外科杂志, 2019, 24(3): 148-150. DOI: 10.13798/j.issn.1009-153X.2019.03.007.
|
[10] |
Wang W, Ge L, Xu XJ, et al. lncRNA NEAT1 promotes endometrial cancer cell proliferation, migration and invasion by regulating the miR-144-3p/EZH2 axis[J]. Radiol Oncol, 2019, 53(4): 434-442. DOI: 10.2478/raon-2019-0051.
|
[11] |
Chen CL, Zhang L, Jiao YR, et al. miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo[J]. FEBS Lett, 2019, 593(10): 1089-1101. DOI: 10.1002/1873-3468.13387.
|
[12] |
Ellert-miklaszewska A, Poleszak K, Pasierbinska M, et al. Integrin signaling in glioma pathogenesis: from biology to therapy[J]. Int J Mol Sci, 2020, 21(3): 888-893. DOI: 10.3390/ijms21030888.
|
[13] |
Wang N, Chang LL. Maspin suppresses cell invasion and migration in gastric cancer through inhibiting EMT and angiogenesis via ITGB1/FAK pathway[J]. Hum Cell, 2020, 33(3): 663-675. DOI: 10.1007/s13577-020-00345-7.
|
[14] |
Wu YJ, Lin SH, Din ZH, et al. Sinulariolide inhibits gastric cancer cell migration and invasion through downregulation of the EMT process and suppression of FAK/PI3K/AKT/mTOR and MAPKs signaling pathways[J]. Mar Drugs, 2019, 17(12): 668-874. DOI: 10.3390/md17120668.
|